Profil
Mr. Adam Townsend is a President, Chief Executive Officer & Director at Merida Biosciences, Inc. He is on the Board of Directors at Merida Biosciences, Inc. Mr. Townsend was previously employed as a Chief Operating Officer by Apellis Pharmaceuticals, Inc., a Senior Vice President-Corporate Development by Biogen, Inc., and a General Manager-UK, Ireland & Nordic Region by EUSA Pharma, Inc. He received his undergraduate degree from Royal Holloway University of London.
Aktive Positionen von Adam Townsend
| Unternehmen | Position | Beginn |
|---|
Ehemalige bekannte Positionen von Adam Townsend
| Unternehmen | Position | Ende |
|---|---|---|
| APELLIS PHARMACEUTICALS, INC. | Geschäftsführer | 21.02.2025 |
| BIOGEN INC. | Corporate Officer/Principal | 01.10.2018 |
EUSA Pharma, Inc.
EUSA Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and researches pharmaceutical products | Corporate Officer/Principal | 01.03.2010 |
Ausbildung von Adam Townsend
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Biogen, Inc.
Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
EUSA Pharma, Inc.
EUSA Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and researches pharmaceutical products | Health Technology |
Apellis Pharmaceuticals, Inc.
Apellis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics and drug delivery technologies to address chronic inflammatory diseases | Health Technology |
Royal Holloway University of London
Royal Holloway University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















